Showing 1,381 - 1,400 results of 45,067 for search '(( 5 ((026 decrease) OR (mean decrease)) ) OR ( 50 ((c decrease) OR (a decrease)) ))', query time: 1.29s Refine Results
  1. 1381
  2. 1382
  3. 1383
  4. 1384
  5. 1385
  6. 1386

    Response of small airway tissues infected with EV-D94 and decreasing doses of EV-D68. by Ines Cordeiro Filipe (5849144)

    Published 2022
    “…<p>Tissues were infected with 1E7 RNA copies of EV-D94 (equivalent to 2,46E4 TCID50) and 1E7 RNA copies of EV-D68 (3,3E5 TCID50) as well as decreasing doses of the latter. …”
  7. 1387
  8. 1388
  9. 1389

    Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to halofantrine (HFN) and related antimalarials. by Daria Van Tyne (168938)

    Published 2011
    “…Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to (A) HFN and structurally related (B) mefloquine (MFQ) and (C) lumefantrine (LUM). …”
  10. 1390
  11. 1391

    Loss of MALS-1 function suppresses the mitochondrial and axon degeneration phenotypes that are caused by loss of RBM-26 function. by Tamjid A. Chowdhury (14149846)

    Published 2024
    “…Control (wild type), <i>rbm-26 (cue23[P80L])</i> and <i>rbm-26 (cue34[L13V])</i> data in panels A, B, and C have been reused from Figs <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3002876#pbio.3002876.g002" target="_blank">2D, 2F</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3002876#pbio.3002876.g005" target="_blank">5C</a>, respectively. …”
  12. 1392
  13. 1393

    Decreased expression of transferrin receptor (TfR) but not transferrin (Tf) in R6/2 HD mice. by Jianfang Chen (469733)

    Published 2013
    “…<b>C</b>-<b>D</b>. Western blot analysis of TfR detects a band migrating at ~95 kDa consistent with TfR (<b>C</b>); this band is significantly decreased in HD as compared to wild-type mice in cortex and striatum (<b>D</b>). …”
  14. 1394
  15. 1395
  16. 1396
  17. 1397
  18. 1398
  19. 1399
  20. 1400

    High-throughput drug screen reveals HDAC and proteasome inhibitors as potent drug classes against synovial sarcoma. by Aimée N. Laporte (3617987)

    Published 2017
    “…(B) The top 40 drug screen hits out of the 900 compound screen represented by drug target class, demonstrate HDAC inhibitors as the most abundant hits in the screen. (C) Compounds that brought about greater than 90% decreased relative cell viability were scored as 1 (+++), 75.1–90% as 0.5 (++), 50–75% as 0.25 (+) and less than 50% as 0 (-). …”